Biosensors International is celebrating a year of significant achievement with an expanded product portfolio, offering physicians a broader range of treatment options to improve patient outcomes.

BIOTRONIK Japan has announced enrollment of the first patient in the BIOFLOW-IV study, which aims to verify the efficacy and safety of the Orsiro Hybrid Drug-Eluting Stent (DES) from BIOTRONIK. The high quality and efficacy of Orsiro has already been confirmed by three important trials, BIOFLOW-I, -II, and –III, which demonstrated the safety and efficacy of Orsiro.

BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced a significant milestone today in the development of a new therapy era for patients suffering from coronary artery disease. As part of the clinical study BIOSOLVE-II, Prof. Dr. Michael Haude from the Lukaskrankenhaus, Neuss, Germany, successfully implanted the BIOTRONIK DREAMS (DRug Eluting Absorbable Metal Scaffold) in the first patient.

CNN reported that the blockage in former President George W. Bush’s coronary artery was “in the ballpark of 95 percent.” He underwent PCI in August, which at the time was criticized as possibly a case of overuse of stenting.

The Greenwich Hospital Auxiliary has made a $500,000 donation to benefit cardiovascular services at Greenwich Hospital. The generous gift was made during the Auxiliary’s 63rd annual meeting on Sept. 30.

No other health concern affects more people in Hunterdon County than cardiovascular disease.  It is the County’s leading cause of death and its incidence is on the rise due, in part, to the growing number of area residents between the age of 45 and 64 – a time in life in which the onset of cardiovascular disease is most likely to occur.  Hunterdon Medical Center has begun construction on its new Cardiovascular Center. The expansion will centralize all acute care cardiovascular services.

Methodist Mansfield Medical Center has received Cycle IV Chest Pain Center Accreditation from the Society of Cardiovascular Patient Care (SCPC), an international not-for-profit organization that focuses on transforming cardiovascular care by assisting facilities in their effort to create communities of excellence that bring together quality, cost and patient satisfaction.

Based on what they describe as a review of several studies and interviews with 37 cardiologists, 33 patients or their survivors, three Bloomberg reporters explored overuse of stenting, particularly in elective procedures. The report covers several investigations and describes cases that culminated in patient deaths. It also includes a map of “coronary stent hot spots.”